![Northwest Biotherapeutics Inc](/common/images/company/L_0K95.png)
Northwest Biotherapeutics Inc (0K95)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -138.818 | -146.168 | -145.823 | -120.109 | -2521.276 | 490.36 | -293.866 | -217.52 |
Return on Equity (%) | 550.832 | 158.6 | 93.708 | 44.741 | 260.665 | -73.572 | 83.328 | 66.406 |
Return on Invested Capital (%) | 865.397 | 175.138 | 105.65 | 65.614 | 44.064 | 23.157 | 67.428 | 87.759 |
Operating Margin (%) | -12262.6 | -20118.452 | -6312.621 | -718.714 | -40377.769 | 18322.09 | -5880.214 | -2968.841 |
Net Profit Margin (%) | -13781.862 | -22145.536 | -13020.388 | -842.158 | -41039.582 | 17823.483 | -6240.761 | -3331.936 |
Book Value Per Share | -0.169 | -0.144 | -0.09 | -0.071 | -0.44 | -0.133 | -0.1 | -0.042 |
Earnings Per Share | -0.547 | -0.226 | -0.103 | -0.033 | -0.639 | 0.189 | -0.098 | -0.056 |
Cash Per Share | 0.039 | N/A | 0.042 | 0.001 | 0.012 | 0.016 | 0.007 | 0.002 |
Working Capital Per Share | -0.436 | -0.262 | -0.088 | -0.062 | -0.442 | -0.123 | -0.109 | -0.036 |
Operating Profit Per Share | 0.004 | 0.001 | 0.001 | 0.004 | 0.002 | 0.001 | 0.002 | 0.002 |
EBIT Per Share | -0.511 | -0.222 | -0.069 | -0.033 | -0.639 | 0.189 | -0.098 | -0.054 |
EBITDA Per Share | -0.511 | -0.222 | -0.069 | -0.033 | -0.639 | 0.189 | -0.098 | -0.054 |
Free Cash Flow Per Share | -0.517 | -0.228 | -0.105 | -0.032 | -0.631 | 0.195 | -0.097 | -0.054 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 157,03M | 328,9M | 523,2M | 614,3M | 829,6M | 948,4M | 1,07B | N/A |
Capitalisation boursière | 197,31M |
Ratio cours/bénéfice | -3,05 |
Ratio prix/ventes | 100 |
Ratio prix/liquidités | 94,44 |
Ratio prix/valeur comptable | -4,17 |
Rendement de dividende | - |
Actions en circulation | 1,15B |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 0,171 |
Plus bas sur 52 semaines | 0,171 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales